HPQ
66
6
GWW
76
2
V
72
-4
TSN
42
3
AMZN
59
3
NVDA
54
2
GE
72
4
MU
36
-6
BWA
48
-5
FCX
57
-2
CPB
40
3
DUK
64
7
AVB
67
2
LEN
57
-4
DAL
79
-4
ALLE
39
-2
ED
55
3
LLY
53
6
AKAM
50
-3
BA
56
-2
HPQ
66
6
GWW
76
2
V
72
-4
TSN
42
3
AMZN
59
3
NVDA
54
2
GE
72
4
MU
36
-6
BWA
48
-5
FCX
57
-2
CPB
40
3
DUK
64
7
AVB
67
2
LEN
57
-4
DAL
79
-4
ALLE
39
-2
ED
55
3
LLY
53
6
AKAM
50
-3
BA
56
-2
Financhill
Back

Black Diamond Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
31

BDTX
Black Diamond Therapeutics

Last Price:
2.57
Seasonality Move:
28.2%
Sell
16

NBY
NovaBay Pharmaceuticals

Last Price:
0.59
Seasonality Move:
1.46%
Sell
31
Black Diamond Therapeutics (BDTX) is a Sell

Is Black Diamond Therapeutics a Buy, Sell or Hold?

  • The current Black Diamond Therapeutics [BDTX] share price is $2.57. The Score for BDTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • BDTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BDTX Stock Price Chart

What is Black Diamond Therapeutics's stock price today?

  • The Black Diamond Therapeutics share price today is $2.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

BDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 37.09 Sell
Chaikin Money Flow: 347120 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.56 - 3.16) Sell
Bollinger Bands (100): (3.22 - 5.86) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 38.02 Sell
Chaikin Money Flow: 12423 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.63 - 0.75) Sell
Bollinger Bands (100): (0.28 - 1.32) Sell

BDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.5 Buy
20-day SMA: 2.84 Sell
50-day SMA: 3.37 Sell
200-day SMA: 4.83 Sell
8-day EMA: 2.58 Sell
20-day EMA: 2.8 Sell
50-day EMA: 3.4 Sell
200-day EMA: 4.24 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Sell
20-day SMA: 0.7 Sell
50-day SMA: 0.67 Sell
200-day SMA: 2.26 Sell
8-day EMA: 0.65 Sell
20-day EMA: 0.67 Sell
50-day EMA: 0.72 Sell
200-day EMA: 5.42 Sell

Black Diamond Therapeutics Earnings Growth & BDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Black Diamond Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):